Business · 1 sources covering this

India's GLP-1 market enters slower growth phase after semaglutide surge

After a near fourfold expansion driven by generic semaglutide launches, India's GLP-1 market is showing signs of moderation as patient onboarding growth slows

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·2h ago
India's GLP-1 market enters slower growth phase after semaglutide surge
After a near fourfold expansion driven by generic semaglutide launches, India's GLP-1 market is showing signs of moderation as patient onboarding growth slows
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/d0c0e71d1d6a076546dc88d5df8af7d5cc1bdc73"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="India's GLP-1 market enters slower growth phase after semaglutide surge"></iframe>

India's GLP-1 market enters slower growth phase after semaglutide surge

How 1 sources are covering this

India's GLP-1 market enters slower growth phase after semaglutide surge

More from Business

Not 9, just 4 subsidised LPG refills for Ujjwala beneficiaries now? Here's what govt says

North Korea's Kim Jong Un hosts Chinese President Xi Jinping, weeks after hosting Russia's Putin

Sigma Advanced Systems secures Rs 22 million artillery shell bodies export order from North America

TCS sets up dedicated business unit for AI-native GCC operations

Reader

Trust & legal

Across the network